Tag: IN.PACT Global Study

Safety and efficacy of IN.PACT Admiral sustained out to five years

In a late-breaking data session at this year’s Vascular Interventional Advances conference (VIVA 2020; 6–8 November, virtual) Thomas Zeller (University Heart Center Freiburg, Bad...
AV access

VIVA 2019: Four-year data from the IN.PACT Global study highlight durable...

Medtronic today announced four-year data from the IN.PACT Global study, which reinforce the long-term durability and safety of the IN.PACT Admiral drug-coated balloon (DCB)...

New data demonstate durability, safety and efficacy for Medtronic’s In.Pact Admiral...

New data, presented in a series of late-breaking clinical trial presentations at the Vascular Interventional Advances (VIVA) 2016 conference in Las Vegas, USA, have...

US FDA approves first drug-coated balloon for treatment of in-stent restenosis

The US Food and Drug Administration (FDA) has approved Medtronic’s IN.PACT Admiral drug-coated balloon as a treatment for in-stent restenosis in patients with peripheral...